贵州百灵：获得“一种治疗糖尿病或其并发症的中药制剂”专利受理

Core Viewpoint - The company has received a patent application acceptance notice from the National Intellectual Property Administration for a traditional Chinese medicine formulation aimed at treating diabetes and its complications, which could enhance intellectual property protection for its ongoing project if granted [1] Group 1 - The patent application number is 202610042695.2, and the invention is based on the company's long-term research in the "Tian Ning Tong Luo" project [1] - The acceptance of the patent application is currently in the review stage, which carries the risk of not passing the examination and being granted [1] - The current status of the patent application will not have a significant impact on the company's operations [1]